深度FusionCDR:采用多omics集成和分子特异变压器来增强癌症药物反应的预测
IEEE journal of biomedical and health informatics
|June 27, 2024
概括
DeepFusionCDR集成了多omics数据和分子变压器,用于优越的癌症药物反应预测. 这种方法提高了识别敏感或耐药细胞系的准确性,为个性化癌症治疗铺平了道路.
科学领域:
- 计算生物学和生物信息学
- 基因组学和精准医学精准医学
- 人工智能在药物发现中的作用
背景情况:
- 目前用于癌症药物反应 (CDR) 预测的深度学习模型通常依赖于单个omics数据,可能缺少关键的生物学见解.
- 整合各种生物数据源对于全面了解细胞对药物反应至关重要.
研究的目的:
- 引入DeepFusionCDR,这是一种用于增强癌症药物反应预测的新型深度学习框架.
- 利用多omics数据和分子特异变压器来提高预测准确性和药物敏感性分类.
主要方法:
- 采用无监督的对比学习来融合来自细胞系的多omics数据 (突变,转录组,甲基组,拷贝数变异).
- 利用特定于SMILES的分子变压器从药物化学结构中提取特征.
- 使用多层感知器 (MLP) 进行IC50值预测和药物敏感性分类的综合多层和药物特征.
主要成果:
- 与最先进的方法相比,DeepFusionCDR在GDSC数据集上的回归 (IC50预测) 和分类 (灵敏度/抗性) 任务中表现出卓越的性能.
- 废除研究和案例分析验证了多奥米克融合和基于变压器的药物特征提取的有效性和多功能性.
- 在TCGA患者数据上的成功预测突出了在现实世界临床场景中的实际适用性.
结论:
- DeepFusionCDR有效地整合了多omics数据和分子药物特征,显著改善了癌症药物反应预测.
- 该框架的识别药物敏感性/耐药性的能力以及它对患者数据的表现强调了其临床翻译的潜力.
- 利用多omics融合和先进的分子变压器为推进精密瘤学提供了一个强大的战略.
更多相关视频
12:41Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
4.8K
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10.2K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K